Philipson TJ - Search Results

1

Health, Wealth, and the 21st Century Cures Act.

Lo AW, Philipson TJ, von Eschenbach AC. Lo AW, et al. Among authors: philipson tj. JAMA Oncol. 2016 Jan;2(1):17-8. doi: 10.1001/jamaoncol.2015.4221. JAMA Oncol. 2016. PMID: 26513279 No abstract available.

2

Long-term ramifications of reimportation for the health care system.

Philipson TJ. Philipson TJ. Manag Care. 2004 Jun;13(6 Suppl):17-8; discussion 18-9, 41-2. Manag Care. 2004. PMID: 15303522 No abstract available.

3

Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?

Philipson TJ, Jena AB. Philipson TJ, et al. AHIP Cover. 2006 Sep-Oct;47(5):29, 31, 33. AHIP Cover. 2006. PMID: 17007325 No abstract available.

4

An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Philipson T, Eber M, Lakdawalla DN, Corral M, Conti R, Goldman DP. Philipson T, et al. Health Aff (Millwood). 2012 Apr;31(4):667-75. doi: 10.1377/hlthaff.2011.1298. Health Aff (Millwood). 2012. PMID: 22492882 Free PMC article.

5

Tutorial on health economics and outcomes research in nutrition.

Philipson T, Linthicum MT, Snider JT. Philipson T, et al. JPEN J Parenter Enteral Nutr. 2014 Nov;38(2 Suppl):5S-16S. doi: 10.1177/0148607114549770. Epub 2014 Sep 19. JPEN J Parenter Enteral Nutr. 2014. PMID: 25239114

6

Defining Value: The Need for a Longer, Broader View.

Philipson TJ, Kamal-Bahl S, Jena AB. Philipson TJ, et al. Pharmacoeconomics. 2017 Jul;35(7):669-672. doi: 10.1007/s40273-017-0503-7. Pharmacoeconomics. 2017. PMID: 28337720 No abstract available.

7

The effect of epidemic measles on immunization rates.

Goldstein KP, Philipson TJ, Joo H, Daum RS. Goldstein KP, et al. Among authors: philipson tj. JAMA. 1996 Jul 3;276(1):56-8. JAMA. 1996. PMID: 8667540

8

Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates.

Berndt ER, Gottschalk AH, Philipson TJ, Strobeck MW. Berndt ER, et al. Among authors: philipson tj. Nat Rev Drug Discov. 2005 Jul;4(7):545-54. doi: 10.1038/nrd1774. Nat Rev Drug Discov. 2005. PMID: 16052239 Review.

9

Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains.

Lakdawalla D, Shafrin J, Lucarelli C, Nicholson S, Khan ZM, Philipson TJ. Lakdawalla D, et al. Among authors: philipson tj. Health Aff (Millwood). 2015 Apr;34(4):555-61. doi: 10.1377/hlthaff.2014.0639. Health Aff (Millwood). 2015. PMID: 25847636 Free PMC article.

10

Cost-effectiveness analysis and innovation.

Jena AB, Philipson TJ. Jena AB, et al. Among authors: philipson tj. J Health Econ. 2008 Sep;27(5):1224-36. doi: 10.1016/j.jhealeco.2008.05.010. Epub 2008 Jun 5. J Health Econ. 2008. PMID: 18619695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page